Affymax (AFFY) wins approval for its drug to treat anemic kidney patients -Bloomberg

March 27, 2012 11:47 AM EDT Send to a Friend
Get Alerts AFFY Hot Sheet
Trade AFFY Now!
Join SI Premium – FREE
Affymax (Nasdaq: AFFY) wins approval for its drug to treat anemic kidney patients


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Momentum Movers

Add Your Comment